Rettori V, Belova N, Dees W L, Nyberg C L, Gimeno M, McCann S M
Department of Physiology, University of Texas Southwestern Medical Center at Dallas 75235-9040.
Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):10130-4. doi: 10.1073/pnas.90.21.10130.
Nitric oxide (NO) synthase, the enzyme which converts arginine into citrulline plus NO, a highly active free radical, has been found in many neurons in the brain, including neurons in the hypothalamus. Our previous experiments showed that norepinephrine-induced prostaglandin E2 release from hypothalamic explants incubated in vitro is mediated by NO. Since the release of luteinizing hormone-releasing hormone (LHRH) is also driven by norepinephrine and prostaglandin E2, we hypothesized that NO might also control pulsatile release of LHRH in vivo, resulting in turn in pulsatile release of luteinizing hormone (LH). To ascertain the role of NO in control of pulsatile LH release in vivo, an inhibitor of NO synthase, NG-monomethyl-L-arginine (NMMA), was microinjected into the third cerebral ventricle (1 mg/5 microliters) of conscious castrate male rats at time 0 and 60 min later; blood samples were taken every 10 min during this period. NMMA blocked pulsatile LH release within 20 min, and plasma LH concentration declined further without pulses after the injection at 60 min. Pulsatile release of LH was not altered in diluent-injected controls. NMMA did not alter pulsatile release of follicle-stimulating hormone, which suggests that its release does not require NO. Incubation of medial basal hypothalami with norepinephrine (10 microM) induced an increase in LHRH release that was inhibited by NMMA (300 microM). NMMA alone did not alter basal LHRH release, whereas it was augmented by sodium nitroprusside (100 microM), which releases NO spontaneously. This augmentation was prevented by hemoglobin (2 micrograms/ml), which binds the NO released by nitroprusside. Our previous experiments showed that norepinephrine-induced release of prostaglandin E2 is mediated by NO. Nitric oxidergic neurons were visualized in the median eminence adjacent to the LHRH terminals. The combined in vivo and in vitro results indicate that the pulsatile release of LHRH induced by norepinephrine is brought about by alpha 1-adrenergic activation of NO synthase. NO then induces prostaglandin E2 release that activates exocytosis of LHRH secretory granules into the portal vessels to induce pulsatile LH release.
一氧化氮合酶是一种将精氨酸转化为瓜氨酸和一氧化氮(一种高活性自由基)的酶,已在大脑中的许多神经元中发现,包括下丘脑的神经元。我们之前的实验表明,去甲肾上腺素诱导的体外培养的下丘脑外植体中前列腺素E2的释放是由一氧化氮介导的。由于促黄体生成素释放激素(LHRH)的释放也受去甲肾上腺素和前列腺素E2驱动,我们推测一氧化氮可能也在体内控制LHRH的脉冲式释放,进而导致促黄体生成素(LH)的脉冲式释放。为了确定一氧化氮在体内控制LH脉冲式释放中的作用,在0分钟和60分钟后,将一氧化氮合酶抑制剂NG-单甲基-L-精氨酸(NMMA)微量注射到清醒去势雄性大鼠的第三脑室(1毫克/5微升);在此期间每10分钟采集一次血样。NMMA在20分钟内阻断了LH的脉冲式释放,在60分钟注射后,血浆LH浓度在无脉冲的情况下进一步下降。在注射稀释剂的对照组中,LH的脉冲式释放没有改变。NMMA没有改变促卵泡激素的脉冲式释放,这表明其释放不需要一氧化氮。用去甲肾上腺素(10微摩尔)孵育内侧基底部下丘脑可诱导LHRH释放增加,这被NMMA(300微摩尔)抑制。单独使用NMMA不会改变基础LHRH释放,而硝普钠(100微摩尔)可自发释放一氧化氮,它可增强LHRH释放。血红蛋白(2微克/毫升)可结合硝普钠释放的一氧化氮,从而阻止这种增强作用。我们之前的实验表明,去甲肾上腺素诱导的前列腺素E2释放是由一氧化氮介导的。在LHRH终末相邻的正中隆起中可观察到一氧化氮能神经元。体内和体外实验结果相结合表明,去甲肾上腺素诱导的LHRH脉冲式释放是由一氧化氮合酶的α1-肾上腺素能激活引起的。然后,一氧化氮诱导前列腺素E2释放,激活LHRH分泌颗粒向门静脉血管的胞吐作用,从而诱导LH的脉冲式释放。